|
Invited
and
Plenary
Lectures
and
Seminars
- “Efficient Co-Delivery of siRNA/Antisense Oligonucleotides and Drug for Lung Cancer Treatment”, 36th Annual Scientific Session of the New Jersey Thoracic Society, New Brunswick, NJ, June 6, 2008.
- “Nanocarriers for Tumor-Targeted Drug Delivery”, 2008 NSTI Nanotech 2008 11th Annual Meeting, NCI/NSTI Special Symposium on Nanotechnology for Cancer Prevention, Diagnosis and Treatment, Boston, MA, June 4, 2008.
- “Targeted Multifunctional Nanocarriers for Tumor Treatment and Imaging”, School of Pharmacy, University of Rhode Island, Kingston, RI, May 15, 2008.
- “Targeted MultifunctionalNanocarriers for Tumor Treatment and Imaging” in the 2nd Annual Meeting “Toward the Development of Drug Delivery Systems”, Perugia, Italy, March 7, 2008.
- “Targeted Multifunctional Nanocarriers for Intracellular Drug Delivery” at the School of Pharmacy, University of Ferrara, Ferrara, Italy, March 5, 2008.
- “Tumor – Targeted Anticancer Prodrugs”, Annual Meeting of the American Association of Pharmaceutical Scientists, San Diego, CA, November 15, 2007.
- “Targeted Multicomponent Nanocarriers for Cancer Treatment and Diagnostics”, The Fifth International Nanomedicine and Drug Delivery Symposium, Boston, MA, November 2, 2007.
- “Multifunctional Drug Delivery System for Inhalatory Treatment of Lung Cancer”, The Biennial New Jersey Pharmaceutical Conference of 2007, New Brunswick, NJ, October 5, 2007.
- “Targeted Multifunctional Nanocarriers for Intracellular Drug Delivery”, Department of Pharmaceutics at the University of Minnesota, Minneapolis, MN, September 20, 2007.
- “Targeted multicomponent nanocarriers in cancer treatment”, the 6th Annual Meeting of the Israeli Chapter of the Controlled Release Society on September 5, 2007, Cesaria, Israel.
- “Targeted multifunctional drug delivery systems for cancer treatment and imaging” Chemistry and Chemical Biology Department at Stevens Institute of Technology, Hoboken, NJ., September 12, 2007.
- “Tumor-specific targeting of drug delivery systems for cancer therapy and imaging”, 34th Annual Meeting of the Controlled Release Society, Long Beach, CA, July 11, 2007.
- “Complex liposomal drug delivery system for inhalatory treatment of lung cancer”, 35th Annual Scientific Session of the New Jersey Thoracic Society, New Brunswick, NJ, June 1, 2007.
- “Targeted Multifunctional Nanocarriers for Intracellular Drug Delivery”, Department of Chemistry, Newark, Rutgers, The State University of New Jersey, Newark, NJ, March 30, 2007.
- “Receptor Targeting of Polymer Therapeutics and Imaging Agents to Tumor”, International Symposium on Polymer Therapeutics ISPT-07, Berlin, Germany, February 20, 2007.
- “Tumor-Specific Targeting of Drug Delivery Systems”, Novartis Pharmaceuticals, East Hanover, NJ, November 17, 2006.
- Targeted Nanocarriers for Intracellular Drug Delivery, Targeted Nanocarriers and Therapeutics, Institute for Translational Medicine and Therapeutics, The University of Pennsylvania School of Medicine, Philadelphia, PA, November 16, 2006.
- “Tumor - Targeting Liposomal Complex for Short Interfering RNA Delivery”, Georgetown University Medical Center, Washington DC, October 24, 2006.
- “Targeted Polymeric Prodrug with Multivalent Components for Cancer Therapy”, the 7th International Biorelated Polymers Symposium at the 232nd American Chemical Society Meeting, San Francisco, CA, September 12, 2006.
- “Molecular targeting of drug delivery system to lung cancer”, 34th Annual Scientific Session of New Jersey Thoracic Society, New Brunswick, NJ, June 2, 2006.
- “Targeted Proapoptotic Drug Delivery System for Chemotherapy of Ovarian Cancer”, The Cancer Institute of New Jersey, New Brunswick, NJ, May 5, 2006.
- “Extracellular and intracellular molecular targeting of drug delivery system to cancer”, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, March 31, 2006.
- “Targeted anticancer polymeric prodrugs”, Abbott Laboratories, Abbott Park, IL, March 23, 2006.
- “Complex drug delivery composition for treating cancer”, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT, February 27, 2006.
- “Advances in targeted drug delivery for cancer treatment”, Bristol-Myers Squibb Co., New Brunswick, NJ, February 3, 2006.
- “Targeted drug delivery systems for cancer therapy”, Department of Biopharmaceutical Sciences, University of Illinois at Chicago, Chicago IL, January 11, 2006.
- “Advanced targeted drug delivery systems for cancer therapy”, International Conference on Advances in Pharmaceutical Research and Technology, Mumbai, India, November 25-29, 2005.
- “Novel approaches in anticancer drug delivery”, The Biennial New Jersey Pharmaceutical Conference of 2005 “Contribution of Women in the Pharmaceutical Sciences”, East Brunswick, NJ, October 6, 2005.
- “Delivery system for remediation of cellular hypoxic damage”, Third International Nanomedicine and Drug Delivery Symposium, Baltimore, MD, September 26-27, 2005.
- “Molecular targeting of drug delivery systems to cancer”, College of Pharmacy, Howard University, Washington, DC, November 4, 2004.
- “Targeted delivery of anticancer drugs and peptides by polyethylene glycol conjugates”, 7th Symposium on Biomaterials Science, New Brunswick, NJ, October 21-22, 2004.
- “Extracellular and intracellular molecular targeting of drug delivery system to cancer cells”, World Conference on Dosing of Antiinfectivnes – Dosing the Magic Bullets, Nurnberg, Germany, September 9-11, 2004.
- “A novel multicomponent delivery system to enhance the efficacy of lung cancer therapy”, 32nd Annual Scientific Section of the New Jersey Thoracic Society, New Brunswick, NJ, June 4, 2004.
- “Targeted proapoptotic anticancer drug delivery system”, College of Pharmacy, University of Maryland, Baltimore, MD, March 3, 2004.
- “Molecular targeting of drug delivery systems to cancer cells by peptides and antisense oligonucleotides”, College of Pharmacy, University of Kentucky, Lexington, KY, February 27, 2004.
- “Molecular targeting of cellular resistance in cancer”, 8th World Congress on Advances in Oncology and 6th International Symposium on Molecular Medicine, Crete, Greece, October 16, 2003.
- “Multicomponent drug delivery system for enhancing the efficacy of cancer chemotherapy”, Meeting of the New Jersey Center for Biomaterials, New Brunswick, NJ, September 17, 2003.
- “Molecular targeting of drug delivery systems to cancer cells by peptides and antisense oligonucleotides”, Department of Biopharmaceutical Sciences, University of Illinois at Chicago, Chicago IL, April 2, 2003.
- “Genetic adaptation to life at high altitude: Adaptation to chronic hypoxia, relevance to disease at sea level”, University of Lima, Lima, Peru, March 14, 2003.
- “Advanced targeted drug delivery systems for cancer therapy”, Myriad Genetics, Inc., Salt Lake City, UT, March 4, 2003.
- “Molecular targeting of drug delivery systems to cancer cells by peptides and antisense oligonucleotides”, EOHSI, Piscataway, NJ, February 6, 2003.
- “Targeted proapoptotic drug delivery systems in cancer chemotherapy”, 7th World Congress on Advances in Oncology and 5th International Symposium on Molecular Medicine, Hersonissos, Crete, Greece, October 11, 2002.
- “Targeted proapoptotic drug delivery systems in cancer chemotherapy”, Cancer Institute of New Jersey (Breast Cancer Research Program), New Brunswick, NJ, May 2002.
- “Advanced drug delivery systems in cancer chemotherapy”, The Screening Technologies Branch of the Developmental Therapeutics Program in Drug Discovery and Development, National Cancer Institute, Frederick, MD, March 2002.
- “Novel drug delivery systems for cancer therapy”, Salvona, Dayton, NJ, January 2002.
- “Enhancing the efficacy of chemotherapeutic drugs by the suppression of antiapoptotic cellular defense”, GPCC Retreat, The Center for Advanced Biotechnology and Medicine, UMDNJ, Piscataway, NJ, December 2001.
- “Advanced drug delivery systems in cancer chemotherapy”, VectraMed, Princeton, NJ, December 2001.
- “Enhancing the efficacy of anticancer drugs using multicomponent advanced drug delivery system”, The Cancer Institute of New Jersey, New Brunswick, NJ, December 2001.
- “Advanced drug delivery systems in cancer chemotherapy”, Pharmaceutics Conference 2001, East Brunswick, NJ, November 2001.
- A polymer drug delivery system for cancer therapy, New Jersey Center for Biomaterials, Piscataway, NJ, June 1, 2001.
- Antitumor activity and cell death signaling pathway of free and polymer-bound doxorubicin. The PH 890, Pharmacy Seminar (Pharmaceutics, Spring 2001), Philadelphia College of Pharmacy, University of the Science, Philadelphia, PA, April 27, 2001.
- Mechanisms of anticancer action of HPMA copolymer-bound doxorubicin, ENZON, Inc., Piscataway, NJ, November 16, 2000.
- Mechanism of anticancer action of HPMA copolymer-bound doxorubicin, 40th Microsymposium "Polymers in Medicine", Czech Republic, July 2000, Special Lecture #4.
- “Cell death signaling pathways and antitumor activity polymer-bound drugs”, Department of Pharmacology and Toxicology, School of Pharmacy, University of Utah, Salt Lake City, UT, November 1999.
- “Adaptation to moderate stress increases the resistance to severe hypoxia”, International Symposium on High-Altitude Medicine, Matsumoto, Japan, September 1992.
- “The criterion for the selection of hypoxic impacts for interval hypoxic training”, International Symposium on Interval Hypoxic Training: Efficiency and Mechanisms of Action, Kiev, Ukraine, September 1992.
- “Oxygen supply-consumption ratio as the criterion of tissue hypoxia”, Hypoxia and Ischemia: Basic and Applied Aspects, Berlin, Germany, September 1991.
- “Primary and secondary disturbances of acid-base homeostasis”, Acid-base and Thermal Homeostasis, Syktyvkar, Russia, February 1991.
- “Influence of adaptation to high altitude hypoxia on the resistance of an organism to oxygen deficiency and stress”, Functional Reserves and Adaptation, Kiev, Ukraine, September 1990.
- “Peculiarities of organism oxygen supply under bronchial asthma in mountains”, Usage of Mountain Climate to Treatment and Prophylaxis, Nalchik, Russia, April 1988.
- “The conformity between oxygen mass transfer and its consumption during hypoxia of different genesis”, Regulation of Respiration and Gas Mass Transfer in the Organism, Leningrad, Russia, April 1985.
|
